Stockreport

Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$142m market cap decline as longer-term profits stay in the green [Yahoo! Finance]

Pyxis Oncology, Inc.  (PYXS) 
PDF 50% of the business is held by the top 9 shareholders Using data from analyst forecasts alongside ownership research, one can better assess the future performance of [Read more]